Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM (1995). «The nuclear receptor superfamily: the second decade». Cell. 83 (6): 835-9. PMID8521507. doi:10.1016/0092-8674(95)90199-X !CS1 manut: Nomes múltiplos: lista de autores (link)
Nuclear Receptors Nomenclature Committee (1999). «A unified nomenclature system for the nuclear receptor superfamily». Cell. 97 (2): 161-3. PMID10219237. doi:10.1016/S0092-8674(00)80726-6
Laudet V (1997). «Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor». J. Mol. Endocrinol. 19 (3): 207-26. PMID9460643. doi:10.1677/jme.0.0190207
Escriva H, Langlois MC, Mendonça RL, Pierce R, Laudet V. Evolution and diversification of the nuclear receptor superfamily. Annals of the New York Academy of Sciences. 1998;839:143–6. doi:10.1111/j.1749-6632.1998.tb10747.x. PMID 9629140.
Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there?. Nature reviews. Drug discovery. 2006;5(12):993–6. doi:10.1038/nrd2199. PMID 17139284.
Benoit G, Cooney A, Giguere V, Ingraham H, Lazar M, Muscat G, Perlmann T, Renaud JP, Schwabe J, Sladek F, Tsai MJ, Laudet V. International Union of Pharmacology. LXVI. Orphan nuclear receptors. Pharmacol. Rev.. 2006;58(4):798–836. doi:10.1124/pr.58.4.10. PMID 17132856.
Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM (1995). «The nuclear receptor superfamily: the second decade». Cell. 83 (6): 835-9. PMID8521507. doi:10.1016/0092-8674(95)90199-X !CS1 manut: Nomes múltiplos: lista de autores (link)
Nuclear Receptors Nomenclature Committee (1999). «A unified nomenclature system for the nuclear receptor superfamily». Cell. 97 (2): 161-3. PMID10219237. doi:10.1016/S0092-8674(00)80726-6
Laudet V (1997). «Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor». J. Mol. Endocrinol. 19 (3): 207-26. PMID9460643. doi:10.1677/jme.0.0190207
Escriva H, Langlois MC, Mendonça RL, Pierce R, Laudet V. Evolution and diversification of the nuclear receptor superfamily. Annals of the New York Academy of Sciences. 1998;839:143–6. doi:10.1111/j.1749-6632.1998.tb10747.x. PMID 9629140.
Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there?. Nature reviews. Drug discovery. 2006;5(12):993–6. doi:10.1038/nrd2199. PMID 17139284.
Benoit G, Cooney A, Giguere V, Ingraham H, Lazar M, Muscat G, Perlmann T, Renaud JP, Schwabe J, Sladek F, Tsai MJ, Laudet V. International Union of Pharmacology. LXVI. Orphan nuclear receptors. Pharmacol. Rev.. 2006;58(4):798–836. doi:10.1124/pr.58.4.10. PMID 17132856.